Douglas J Swirsky insider trades
Open-market stock purchases and sales by Douglas J Swirsky, CHIEF FINANCIAL OFFICER at Maxcyte, Inc, from SEC Form 4 filings since Jan 20, 2010.
Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +69%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 17, 2026 | MXCT Maxcyte, Inc | Sold | $8.3K |
Companies traded
- MXCT Maxcyte, Inc: 1 buy, 2 sales, last Mar 17, 2026
- CLRB Cellectar Biosciences, Inc: 1 buy, last Feb 14, 2025
- NRBO NeuroBo Pharmaceuticals, Inc: other filings, last Sep 1, 2020
- FCSC Fibrocell Science, Inc: other filings, last Dec 13, 2019
- RNN Rexahn Pharmaceuticals, Inc: other filings, last Nov 14, 2018
- PTX Pernix Therapeutics Holdings, Inc: other filings, last May 22, 2018
- GNVC Genvec Inc: 15 buys, last Jun 16, 2017
- PYMX.OB Polymedix, Inc: other filings, last Mar 26, 2012